Three projects, funded by the U.S. Department of Energy (DOE), leverage Berkeley Lab’s strengths in artificial intelligence, sensors, and ecological biology to make agriculture more sustainable and more profitable. They aim to quantify and reduce the carbon intensity of agriculture—including the farming of biofuel feedstocks such as corn, soy, and sorghum—while also increasing yield. Two of the new projects are part of the SMARTFARM program of DOE’s Advanced Research Projects Agency-Energy (ARPA-E). This initiative aspires to make the biofuel supply chain carbon negative, which would greatly improve biofuel’s benefits to the broader economy and environment.
Laser, Biosciences Researchers Combine Efforts to Study Viruses in Droplets
Berkeley Lab researchers with expertise in lasers and in biology are working together to develop a platform and experiments to study the structure and components of viruses and to learn how they interact with their surrounding environment. The experiments could provide new insight on how to reduce the infectiousness of viruses such as the one causing COVID-19.
Bristow Helps Bring Test and Trace to Rural Communities
In mid-March, Dr. Jim Bristow’s wife couldn’t stop coughing. Her symptoms pointed to coronavirus, but she couldn’t get tested — in part because of the nationwide test shortage, but also because the pair lived in Vashon, an idyllic town on an island in Washington State’s Puget Sound with scant medical resources.
Using Machine Learning to Estimate COVID-19’s Seasonal Cycle
A cross-disciplinary team of Berkeley Lab scientists with expertise in climate modeling, data analytics, machine learning, and geospatial analytics is launching a project to determine if the novel coronavirus might be seasonal. The team will apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts.
X-ray Experiments Zero in on COVID-19 Antibodies
Data gathered at Berkeley Lab’s Advanced Light Source (ALS) by an international team of researchers indicate that antibodies derived from SARS survivors could potently block entry of SARS-CoV-2 and other closely related coronaviruses into host cells. Such antibodies could be used as a preventative treatment or as a post-exposure therapy.
- « Previous Page
- 1
- …
- 66
- 67
- 68
- 69
- 70
- …
- 207
- Next Page »
Was this page useful?
![like](https://biosciences.lbl.gov/wp-content/plugins/lbl-feedback/assets/thumb_up.png)
![not like](https://biosciences.lbl.gov/wp-content/plugins/lbl-feedback/assets/thumb_down.png)